Invicta Diagnostic Complete Financial Statements
In FYNone, Invicta Diagnostic (INVICTA) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 15.6% and ROE of 10.0%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse INVICTA FII DII holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
INVICTA Revenue, Net Profit & EBITDA — Year-on-Year Growth
INVICTA YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. For live price, earnings ratios and company overview, see Invicta Diagnostic share price screener.
INVICTA Income Statement — Revenue, EBITDA & Net Profit
Invicta Diagnostic revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 15.6%. Also explore INVICTA price trends to track price trends across different timeframes.
| Particulars | None | March 2026 | March 2025 | March 2024 |
|---|---|---|---|---|
| Revenue | 0 | 32 | 31 | 8 |
| Expenses | 0 | 23 | 21 | 5 |
| EBITDA | 0 | 10 | 10 | 4 |
| Operating Profit Margin % | 0.00% | 30.00% | 30.00% | 43.00% |
| Depreciation | 0 | 3 | 3 | 1 |
| Interest | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 7 | 7 | 3 |
| Tax | 0 | 2 | 2 | 0 |
| Net Profit | 0 | 5 | 5 | 3 |
| Earnings Per Share (₹) | 0.00 | 4.90 | 5.57 | 3.19 |
INVICTA Balance Sheet — Assets, Liabilities & Shareholders' Equity
INVICTA total assets ₹60 Cr, total equity ₹50 Cr, total liabilities ₹ Cr (2026) — ROE 10.0%.
| Particulars | 2026 | 2025 | 2024 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 60 | 21 | 16 |
| Current Assets | 34 | 6 | 4 |
| Fixed Assets | 19 | 10 | 12 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 |
| Other Assets | 0 | 12 | 4 |
| LIABILITIES | |||
| Total Liabilities | |||
| Current Liabilities | 3 | 3 | 3 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 50 | 16 | 11 |
| Share Capital | 13 | 8 | 0 |
| Reserves & Surplus | 37 | 8 | 12 |
INVICTA Cash Flow Statement — Operating, Investing & Financing
Invicta Diagnostic operating cash flow ₹7 Cr, investing ₹-5 Cr, financing ₹0 Cr, net cash flow ₹1 Cr (2025).
| Particulars | March 2025 | March 2024 |
|---|---|---|
| Operating Activities | 7 | 4 |
| Investing Activities | -5 | -10 |
| Financing Activities | 0 | 7 |
| Net Cash Flow | 1 | 1 |